With a robust background in venture capital, the fund manager has successfully executed over 50 investments across technology and healthcare sectors, particularly in North America and Europe. Emphasizing a data-driven approach, they focus on early-stage companies with scalable business models. Their strategic style has led to several notable exits, including a significant acquisition in the biotech space, showcasing a knack for identifying high-growth opportunities. This experience positions them as a formidable player in the investment landscape.